News
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...
3d
Live Science on MSNOzempic pill? Trial suggests new oral drug works as well as injectables for type 2 diabetesThe drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results